Dana Shor

Dana Shor
Cambridge University Hospitals NHS Foundation Trust · Department of Oncology (Addenbrooke)

About

8
Publications
262
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
68
Citations

Publications

Publications (8)
Article
Aims Sinonasal malignancies are rare; the most common histological subtype is squamous cell carcinoma (SCC). No randomised trial data exist to guide treatment decisions, with options including surgery, radiotherapy and chemotherapy. The role and sequence of a primary non-surgical approach in this disease remains uncertain. The aim of this study was...
Poster
British Journal of Haematology, 173, (Suppl. 1), page 80 (10.1111/bjh.14019) Joint 1st Authors: James Russell, S Wedderburn Joint Last Authors: A Hodson, M Prahladan
Poster
British Journal of Haematology, 173, (Suppl. 1), page 114 Joint 1st Authors: James Russell, Dana Shor Joint Last Authors: M Prahladan, A Hodson
Article
Isoflavones, a group of phytoestrogens, are selective oestrogen receptor (ER) modulators. They may positively impact endocrine-related conditions but the current evidence is sparse. Equol, a non-steroidal oestrogen, is produced by the metabolism of the isoflavone daidzein by intestinal bacteria. In Western countries, 30-50% of individuals metaboliz...

Network

Cited By